Forecasts data is unavailable for this security.
Consensus recommendation
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Artiva Biotherapeutics Inc have a median target of 22.00, with a high estimate of 23.00 and a low estimate of 18.00. The median estimate represents a 67.81% increase from the last price of 13.11.
High | 75.4% | 23.00 |
Med | 67.8% | 22.00 |
Low | 37.3% | 18.00 |
Earnings history & estimates in USD
More ▼